Moreover, miR-138-5p was validated to target sirtuin 1 (SIRT1) [89]; although limited studies reported the association between SIRT1 and GDM, reliable data confirmed its implication in the inflammation and glucose metabolic pathway in human placenta. The gene discussed is SIRT1; the disease is gestational diabetes.